| abstract |
In general, the present invention includes compounds of formulas (I) and (II) below, including pharmaceutically acceptable salts. The compounds of the present invention are useful as protein kinase inhibitors, and thus for the treatment of cancer and other protein kinase mediated diseases.n n n <Formula I>n n n n n n n n <Formula II>n n n n n n n n Conjugated heterocyclic kinase inhibitors, protein kinase mediated diseases, cancer |